Latest Global Growth News

WCM Global Growth reported a $66.7 million profit for FY2026, slightly down from last year, but boosted its final dividend and outlined a progressive dividend increase plan while completing a major $84.8 million capital raising.

Munro Partners has agreed to buy GSFM Pty Limited, the parent company of GSFM Responsible Entity Services, which manages three Munro-branded ETFs. The deal is expected to close in Q4 2026, with potential shifts in board composition but no disruption to fund management.

The WCM Quality Global Growth Fund posted a -5.20% return in July 2026, underperforming its MSCI benchmark as semiconductor stocks faltered. Despite short-term setbacks, the fund maintains strong long-term outperformance and is increasing exposure to AI-related companies.

WAM Strategic Value delivered a solid 9.5% portfolio return for FY2026, outpacing the ASX All Ordinaries by 3.8%, while declaring a fully franked dividend of 6.5 cents per share. New capital gains tax rules are reshaping investor appetite, boosting demand for listed investment companies like WAM.

Ava Risk Group has appointed Bryant Henson as CEO to spearhead its next growth phase, with a sharp focus on expanding its footprint in the United States and strengthening commercial execution worldwide.

Advanced Braking Technology (ASX: ABV) posted a record $6.2 million in product sales for Q4 FY26, lifting full-year revenue 22.7% to $23.5 million. The company’s autonomous BRAKEiQ system advanced key milestones as international engagement expanded.

Biome Australia (ASX: BIO) edged close to breakeven in FY26, driven by $1.8 million in international sales across four markets and a 68% gross margin. The company is set to launch onshore manufacturing and a digital health platform to accelerate growth.

WCM Global Growth Limited delivered a stellar 19.28% return in the June quarter, outpacing its MSCI benchmark, while announcing a series of progressive fully franked dividends through FY2027.

Orthocell Limited has posted record revenue for FY2026, driven by strong sales growth of Remplir™ and Striate+™ products in Australia, the US, and new international markets, supported by a robust $44.1 million cash position.

Future Generation Global (ASX: FGG) posted a robust 22.7% total shareholder return for the year to June 2026, driven by share price gains and fully franked dividends, while increasing its interim dividend by 5%.

Fluence Corporation has secured two seawater desalination contracts in Vietnam worth approximately US $3.7 million. The projects, set for completion by year-end 2026, will produce up to 7,500 cubic metres of potable water daily on Phu Quoc Island, addressing critical water scarcity.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.